Potential of Competitive Antagonists of Insect Ionotropic γ-Aminobutyric Acid Receptors as Insecticides

Ionotropic γ-aminobutyric acid (GABA) receptors (GABARs) represent an important insecticide target. Currently used GABAR-targeting insecticides are non-competitive antagonists (NCAs) of these receptors. Recent studies have demonstrated that competitive antagonists (CAs) of GABARs have functions of inhibiting insect GABARs similar to NCAs and that they also exhibit insecticidal activity. CAs have different binding sites and different mechanisms of action compared to those of NCAs. Therefore, GABAR CAs should have the potential to be developed into novel insecticides, which could be used to overcome the developed resistance of insect pests to conventional NCA insecticides. Although research on insect GABAR CAs has lagged behind that on mammalian GABAR CAs, research on the CAs of insect ionotropic GABARs has made great progress in recent years, and several series of heterocyclic compounds, such as 3-isoxazolols and 6-iminopyridazines, have been identified as insect GABAR CAs. In this review, we briefly summarize the design strategies, structures, and biological activities of the novel GABAR CAs that have been found in the past decade. Updated information about GABAR CAs may benefit the design and development of novel GABAR-targeting insecticides.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:68

Enthalten in:

Journal of agricultural and food chemistry - 68(2020), 17 vom: 29. Apr., Seite 4760-4768

Sprache:

Englisch

Beteiligte Personen:

Liu, Genyan [VerfasserIn]
Wu, Yun [VerfasserIn]
Gao, Ya [VerfasserIn]
Ju, Xiulian [VerfasserIn]
Ozoe, Yoshihisa [VerfasserIn]

Links:

Volltext

Themen:

3-isoxazolols
56-12-2
6-iminopyridazines
Competitive antagonists
GABA Antagonists
GABA receptors
Gamma-Aminobutyric Acid
Insect Proteins
Insecticides
Journal Article
Receptors, GABA
Review

Anmerkungen:

Date Completed 29.12.2020

Date Revised 29.12.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.jafc.9b08189

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM308285921